CSII News and Press, Cardiovascular Systems Inc. From 01/13/22

Complementary technology to orbital atherectomy expands CSI’s vessel prep market opportunity Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for ...

Live Webcast at 8:00 a.m. CT (9:00 a.m. ET) In a press release issued under the same headline on January 6, by Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), please note that the registration link to participate in the conference call was inaccurate. ...

Live Webcast at 8:00 a.m. CT (9:00 a.m. ET) Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will host a live webcast of its fiscal 2022 second-quarter conference call on Thursday, February 3, 2022, at 8:00 a.m. CT (9:00 a.m. ET). CSI management will discuss...

Shares of Cardiovascular Systems (CSII -6.5%) hit a 52-week low today as the stock continues to suffer following the Nov. 24. recall of the company's WIRION Embolic Protection System. The recall is due to potential filter breakage. The company is recalling 697 devices were distributed in the&...

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) has initiated a voluntary recall of unused WIRION Embolic Protection Systems (WIRION) due to complaints of filter breakage during retrieval. CSI has informed all affected healthcare facilities to discontinue use of WIRION...

Competitive headwinds and concerns over reimbursement, have triggered another downgrade for Cardiovascular Systems (CSII -1.7%) on Wall Street. This time, Needham has cut its recommendation on the stock to Hold from Buy arguing that the company’s recent released financials for first qu...

The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Cardiovascular Systems, Inc. 2022 Q1 - Results - Earnings Call Presentation

Cardiovascular Systems (NASDAQ:CSII) is trading ~1.7% lower in the pre-market after Guggenheim downgraded the stock to Neutral from Buy, citing headwinds related to reimbursement rates and competition. While the medical device company lagged firm’s expectations only marginall...

Cardiovascular Systems, Inc. (CSII) Q1 2022 Results Earnings Conference Call November 09, 2021, 9:00 am ET Company Participants Jack Nielsen - Vice President, Investor Relations & Corporate Communications Scott Ward - Chairman, President, Chief Executive Officer Jeff Points - Chief Financ...

Image source: The Motley Fool. Cardiovascular Systems, inc (NASDAQ: CSII) Q1 2022 Earnings Call Nov 9, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: Cardiovascular Systems, inc (CSII) Q1 2022 Earnings Call Transcr...